Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Japanese Journal of Clinical Oncology|April 26, 2023
A new era of the Asian clinical research network: a report from the ATLAS international symposiumMitsumi Terada, Kenichi Nakamura, Tomohiro Matsuda, et al.
Cancer Cell International|February 4, 2023
Changes in HER3 expression profiles between primary and recurrent gynecological cancersYuki Kojima, Kazuki Sudo, Hiroshi Yoshida, et al.
Cancer Medicine|August 4, 2023
Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosisKengo Hiranuma, Yuka Asami, Mayumi Kobayashi Kato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategiesKazuki Sudo, Takashi Taketa, Arlene M Correa, et al.
Frontiers in Oncology|April 13, 2023
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancerTomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai, et al.
Cancers|May 28, 2022
Clinical Application of Comprehensive Genomic Profiling Tests for Diffuse GliomasTakaki Omura, Masamichi Takahashi, Makoto Ohno, et al.
Cancer Research|June 8, 2014
Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like propertiesShumei Song, Jaffer A Ajani, Soichiro Honjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancerKazuki Sudo, Lianchun Xiao, Roopma Wadhwa, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinomaTakashi Taketa, Kazuki Sudo, Arlene M Correa, et al.
Pageof 14